Company: INSP
Filing Date: 2025-05-05
Form Type: 10-Q
Source: 0001609550-25-000020
Chunk: 128

Company: Inspire Medical Systems, Inc.
Filing Date: 2025-05-05
Form: 10-Q
Item: Part I, Item 3
Chunk 128
---
 have used their existing Inspire IV inventory, which is expected to primarily occur in the second quarter of 2025. 

Because our quarterly and annual results may fluctuate, period-to-period comparisons may not be the best indication of the underlying results of our business and should only be relied upon as one factor in determining how our business is performing. These fluctuations may also increase the likelihood that we will not meet our forecasted performance, which could negatively affect the market price for our common stock.

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds.

Unregistered Sales of Equity Securities

None.

Share Repurchases

The following table presents information with respect to the repurchase of our common stock during the three months ended March 31, 2025:

PeriodTotal Number of Shares Purchased(1)Average Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Program(1)Approximate Dollar Value of Shares that May Yet Be Repurchased Under the Program (in thousands)January 1, 2025 - January 31, 2025—$— —$75,000 February 1, 2025 - February 28, 2025138,203$180.89 138,203$50,000 March 1, 2025 - March 31, 2025304,446$164.23 304,446$— Total442,649442,649

(1) On August 6, 2024, we announced that our Board of Directors authorized the repurchase of up to $150.0 million of our outstanding shares of common stock from time to time through open market transactions, privately negotiated transactions, tender offers, or other means. We are not obligated to repurchase any specific number of shares and the program may be modified, suspended, or discontinued at any time. The share repurchase program was set to expire on August 5, 2026, subject to the earlier termination or extension by the Board, in its sole discretion and without prior notice. As of March 31, 2025, no amount remained available for future repurchases under the share repurchase program.